GH1 and chronic kidney disease: Treatment with growth hormone [57], IL-1 receptor blockers such as anakinra [58] and Vitamin D supplementation [59] reduce WAT browning in CKD models highlighting several potential pathways that contribute to this process in CKD and that may be amenable to intervention.